Publication date: Jul 02, 2025
The COVID-19 pandemic significantly disrupted multiple dimensions of care for adults with cardiovascular disease (CVD) and its associated risk factors. We investigated the changes in health access, disease awareness, treatment, and control among adults with CVD or CVD risk factors after the pandemic. We analyzed National Health and Nutrition Examination Survey (NHANES) data from January 2015 to August 2023 of a civilian adult US population aged ≥20 years. We assessed independent measures of the management of hypertension (HTN), hyperlipidemia (HLD), and diabetes (DM) among participants and health access post-COVID-19. Treatment was defined as a positive response to medical therapy. Control was defined as values that achieved recommended targets of hemoglobin A1C
| Concepts | Keywords |
|---|---|
| Adults | COVID-19 |
| August | CVD prevention |
| Diabetes | CVD risk factors |
| Pandemic | diabetes |
| Therapy | hyperlipidemia |
| hypertension |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Cardiovascular Disease |
| disease | MESH | COVID-19 pandemic |
| disease | MESH | hypertension |
| disease | MESH | hyperlipidemia |